The dual angiogenesis/metastasis inhibitor PG545 inhibits growth factor-induced cell migration and invasion in vitro and tumor growth in vivo of ovarian cancer cells
Angiogenesis business.industry Growth factor medicine.medical_treatment Obstetrics and Gynecology Cell migration medicine.disease In vitro Metastasis Oncology In vivo Ovarian cancer cells Cancer research medicine Tumor growth business